Lupin Limited (NSE:LUPIN)
India · Delayed Price · Currency is INR 2,315.10
-18.70 (-0.80%)
Apr 13, 2026, 3:29 PM IST
Lupin Market Cap
Lupin has a market cap or net worth of 1.06 trillion as of April 14, 2026. Its market cap has increased by 11.07% in one year.
Market Cap
1.06T
Enterprise Value
1.06T
Revenue
261.51B
Ranking
n/a
PE Ratio
22.76
Stock Price
2,315.10
Market Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 1.06T, an increase of 105,813.00%. That is a compound annual growth rate of 29.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 1.06T | 9.58% |
| Dec 31, 2025 | 964.76B | -10.05% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 1.61T |
| Cipla | 978.31B |
| Zydus Lifesciences | 928.15B |
| Mankind Pharma | 857.61B |
| Aurobindo Pharma | 778.16B |
| Alkem Laboratories | 641.41B |
| Glenmark Pharmaceuticals | 618.89B |
| Laurus Labs | 587.26B |